These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 24965746)

  • 21. Metastasis Prevention: Focus on Metastatic Circulating Tumor Cells.
    Menyailo ME; Bokova UA; Ivanyuk EE; Khozyainova AA; Denisov EV
    Mol Diagn Ther; 2021 Sep; 25(5):549-562. PubMed ID: 34287797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluid Shear Stress Induces EMT of Circulating Tumor Cells via JNK Signaling in Favor of Their Survival during Hematogenous Dissemination.
    Xin Y; Li K; Yang M; Tan Y
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33143160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice.
    Zhao XH; Wang ZR; Chen CL; Di L; Bi ZF; Li ZH; Liu YM
    World J Gastroenterol; 2019 Jan; 25(1):138-150. PubMed ID: 30643364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epithelial‑mesenchymal transition phenotype of circulating tumor cells is associated with distant metastasis in patients with NSCLC.
    Zhang X; Wei L; Li J; Zheng J; Zhang S; Zhou J
    Mol Med Rep; 2019 Jan; 19(1):601-608. PubMed ID: 30483792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer metastasis through the prism of epithelial-to-mesenchymal transition in circulating tumor cells.
    Micalizzi DS; Haber DA; Maheswaran S
    Mol Oncol; 2017 Jul; 11(7):770-780. PubMed ID: 28544498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating Tumor Cells from Different Vascular Sites Exhibit Spatial Heterogeneity in Epithelial and Mesenchymal Composition and Distinct Clinical Significance in Hepatocellular Carcinoma.
    Sun YF; Guo W; Xu Y; Shi YH; Gong ZJ; Ji Y; Du M; Zhang X; Hu B; Huang A; Chen GG; Lai PBS; Cao Y; Qiu SJ; Zhou J; Yang XR; Fan J
    Clin Cancer Res; 2018 Feb; 24(3):547-559. PubMed ID: 29070526
    [No Abstract]   [Full Text] [Related]  

  • 27. Plasticity of disseminating cancer cells in patients with epithelial malignancies.
    Bednarz-Knoll N; Alix-Panabières C; Pantel K
    Cancer Metastasis Rev; 2012 Dec; 31(3-4):673-87. PubMed ID: 22733306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EMT-like circulating tumor cells in ovarian cancer patients are enriched by platinum-based chemotherapy.
    Chebouti I; Kasimir-Bauer S; Buderath P; Wimberger P; Hauch S; Kimmig R; Kuhlmann JD
    Oncotarget; 2017 Jul; 8(30):48820-48831. PubMed ID: 28415744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating Tumor Cells with Stemness and Epithelial-to-Mesenchymal Transition Features Are Chemoresistant and Predictive of Poor Outcome in Metastatic Breast Cancer.
    Papadaki MA; Stoupis G; Theodoropoulos PA; Mavroudis D; Georgoulias V; Agelaki S
    Mol Cancer Ther; 2019 Feb; 18(2):437-447. PubMed ID: 30401696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. P-Akt/miR‑200 signaling regulates epithelial-mesenchymal transition, migration and invasion in circulating gastric tumor cells.
    Yuan D; Xia H; Zhang Y; Chen L; Leng W; Chen T; Chen Q; Tang Q; Mo X; Liu M; Bi F
    Int J Oncol; 2014 Dec; 45(6):2430-8. PubMed ID: 25200917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer.
    Guan X; Ma F; Li C; Wu S; Hu S; Huang J; Sun X; Wang J; Luo Y; Cai R; Fan Y; Li Q; Chen S; Zhang P; Li Q; Xu B
    Cancer Commun (Lond); 2019 Jan; 39(1):1. PubMed ID: 30606259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating tumor cell as the functional aspect of liquid biopsy to understand the metastatic cascade in solid cancer.
    Cortés-Hernández LE; Eslami-S Z; Alix-Panabières C
    Mol Aspects Med; 2020 Apr; 72():100816. PubMed ID: 31377345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients.
    Kallergi G; Papadaki MA; Politaki E; Mavroudis D; Georgoulias V; Agelaki S
    Breast Cancer Res; 2011 Jun; 13(3):R59. PubMed ID: 21663619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating tumour cells and the epithelial mesenchymal transition in colorectal cancer.
    Lim SH; Becker TM; Chua W; Ng WL; de Souza P; Spring KJ
    J Clin Pathol; 2014 Oct; 67(10):848-53. PubMed ID: 25008452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epithelial-mesenchymal transition and GALC expression of circulating tumor cells indicate metastasis and poor prognosis in non-small cell lung cancer.
    Liu DG; Xue L; Li J; Yang Q; Peng JZ
    Cancer Biomark; 2018; 22(3):417-426. PubMed ID: 29758927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CCL5 promotes the epithelial-mesenchymal transition of circulating tumor cells in renal cancer.
    Guan Y; Liu X; Tian J; Yang G; Xu F; Guo N; Guo L; Wan Z; Huang Z; Gao M; Chong T
    J Transl Med; 2024 Sep; 22(1):817. PubMed ID: 39227943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epithelial-mesenchymal plasticity and circulating tumor cells: Travel companions to metastases.
    Francart ME; Lambert J; Vanwynsberghe AM; Thompson EW; Bourcy M; Polette M; Gilles C
    Dev Dyn; 2018 Mar; 247(3):432-450. PubMed ID: 28407379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Matrix metalloproteinase 1 and circulating tumor cells in early breast cancer.
    Cierna Z; Mego M; Janega P; Karaba M; Minarik G; Benca J; Sedlácková T; Cingelova S; Gronesova P; Manasova D; Pindak D; Sufliarsky J; Danihel L; Reuben JM; Mardiak J
    BMC Cancer; 2014 Jun; 14():472. PubMed ID: 24972610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mesenchymal marker and LGR5 expression levels in circulating tumor cells correlate with colorectal cancer prognosis.
    Wang W; Wan L; Wu S; Yang J; Zhou Y; Liu F; Wu Z; Cheng Y
    Cell Oncol (Dordr); 2018 Oct; 41(5):495-504. PubMed ID: 29949050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EpCAM-independent isolation of circulating tumor cells with epithelial-to-mesenchymal transition and cancer stem cell phenotypes using ApoStream® in patients with breast cancer treated with primary systemic therapy.
    Le Du F; Fujii T; Kida K; Davis DW; Park M; Liu DD; Wu W; Chavez-MacGregor M; Barcenas CH; Valero V; Tripathy D; Reuben JM; Ueno NT
    PLoS One; 2020; 15(3):e0229903. PubMed ID: 32214335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.